Novel Inhibitor against Rac1 for Therapeutic Approach in Prevention of Breast Cancer Progression

Scientists developed peptide FGDWS as novel inhibitor targeting Rac1-Tiam1 binding site by in-silico as it was found to be the strongest interacting peptide with Rac1 at the Tiam binding site.